Cargando…
Mortality risk of antipsychotic augmentation for adult depression
IMPORTANCE: Randomized controlled trials have demonstrated increased all-cause mortality in elderly patients with dementia treated with newer antipsychotics. It is unknown whether this risk generalizes to non-elderly adults using newer antipsychotics as augmentation treatment for depression. OBJECTI...
Autores principales: | Gerhard, Tobias, Stroup, T. Scott, Correll, Christoph U., Setoguchi, Soko, Strom, Brian L., Huang, Cecilia, Tan, Zhiqiang, Crystal, Stephen, Olfson, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526884/ https://www.ncbi.nlm.nih.gov/pubmed/32997687 http://dx.doi.org/10.1371/journal.pone.0239206 |
Ejemplares similares
-
T232. EFFICACY AND SAFETY OF ANTIDEPRESSANT AUGMENTATION OF ANTIPSYCHOTICS IN SCHIZOPHRENIA
por: Galling, Britta, et al.
Publicado: (2018) -
Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder
por: Sultan, Ryan S., et al.
Publicado: (2019) -
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research
por: Potkin, Steven G., et al.
Publicado: (2020) -
Clinical predictors of therapeutic response to antipsychotics in schizophrenia
por: Carbon, Maren, et al.
Publicado: (2014) -
Body mass index and all-cause mortality in a 21(st) century U.S. population: A National Health Interview Survey analysis
por: Visaria, Aayush, et al.
Publicado: (2023)